English
This article is from Advanced Biomedical Research , volume 2 . Abstract Background:: CD4+(TH1, and TH2) cell groups in the point of view of chemokine receptor expression were considered in blood of stomach cancer patients. Materials and Methods:: The percentage of blood CD4+ T cells expressing chemokine receptors (before and after gastrectomy) was determined by flow cytometry (Becton Dickinson, USA) using the following chemokine receptor antibodies: anti-CCR5, anti-CXCR3, anti-CCR3 and anti-CCR4. Results:: The means of CD4+ CCR5+ expressing cells was 1.23% ± 0.90, 0.83% ± 0.34 and 1.34% ± 0.74 in control, pre- and post-operation groups, respectively. CD4+ CXCR3+ expressing cells were 19.09% ± 8.4, 16.95% ± 5.71 and 25.08% ± 9.31, respectively. Similar pattern was seen for CD4+ CCR3+ and CD4+ CCR4+ expressing cells. Pearson correlation analysis shows no relationship between CCR3 and CCR4 expressions on TCD4 cells (r = 0.211, P = 0.126). The complex expression TH1 (CD4+ CXCR3+ CCR5+) receptors determined 1.14% ± 0.54 for control group, 0.86% ± 0.49 for pre-T and 1.57% ± 0.67 for post-T group. Moreover, the TH2 (CD4+ CCR3+ CCR4+) expression was 1.60% ± 1.05 for control group, 1.57% ±
Sign in with your free account to read, download EPUBs or listen.
Ebook · CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4+ lymphocytes in gastric cancer patients. · Andalib, Alireza, Doulabi, Hassan, Maracy, Mohammad Reza, Rezaei, Abbas, Hasheminia, Seyed Javad · Internet Archive